. Matériels and . .. Méthodes, 19 2.6. Stabilité des solutions de méfloquine en présence de cyclodextrines

. .. Résultats, 2. Étude de la solubilité du chlorhydrate de méfloquine

P. H. Mechelynck and W. Schietecatte, Solubilité de l'acide éthylènediaminotétraacétique (complexon ii) en fonction du ph, Analytica Chimica Acta, vol.19, pp.577-579, 1958.

J. J. Baumy and G. Brule, Etude comparée de la solubilité et de la viscosité des solutions de caséinate et paracaséinate de sodium en présence de calcium, Le Lait, vol.66, issue.1, pp.65-77, 1986.

R. .. Étude-de-l'interaction-méfloquine--cyclodextrine-par, .32 3.5. Stabilité des solutions de méfloquine en présence de cyclodextrines

. .. Discussion, Étude de l'interaction méfloquine-cyclodextrine

. .. Bibliographie, BIBLIOGRAPHIE, Mammalia, vol.58, issue.1, 1994.

. .. Annexes, LE GROUPE DE RECHERCHE MÉDIAS ET SANTÉ, Les médias et la santé, pp.IX-XII, 2010.

Y. Beigbeder, Strategy and programmes, The World Health Organization, pp.20-36, 2017.

P. Schlagenhauf, M. Adamcova, L. Regep, M. T. Schaerer, S. Bansod et al., Use of mefloquine in children - a review of dosage, pharmacokinetics and tolerability data, Malaria Journal, vol.10, issue.1, p.292, 2011.

, Bulletin des Nations Unies, Lake Success, juillet 1950. «Paix mondiale et santé mondiale» par Rajkumari Amrit Kaur, ministre de la Santé publique de l'Inde, présidente de la troisième Assemblée mondiale de la santé., Revue Internationale de la Croix-Rouge et Bulletin international des Sociétés de la Croix-Rouge, vol.32, issue.381, p.692, 1950.

, Guidelines for contributors, Bulletin of the World Health Organization, vol.93, issue.1, pp.63-64, 2015.

, Agence nationale de sécurité du médicament et des produits de santé, Journal de Pédiatrie et de Puériculture, vol.26, issue.1, pp.67-72, 2013.

F. Marçon, Paediatric Needs: Challenge and Opportunities for Hospital Pharmacists, Pharmaceutical Technology in Hospital Pharmacy, vol.0, issue.0, pp.47-55, 2018.

P. M. Lim and . Hydrochloride, Mefloquine Hydrochloride, Analytical Profiles of Drug Substances, vol.14, pp.157-180, 1985.

A. Dassonville-klimpt, C. Cézard, C. Mullié, P. Agnamey, A. Jonet et al., Absolute Configuration and Antimalarial Activity oferythro-Mefloquine Enantiomers, ChemPlusChem, vol.78, issue.7, pp.642-646, 2013.

J. M. Karle, R. Olmeda, L. Gerena, and W. K. Milhous, Plasmodium falciparum: Role of Absolute Stereochemistry in the Antimalarial Activity of Synthetic Amino Alcohol Antimalarial Agents, Experimental Parasitology, vol.76, issue.4, pp.345-351, 1993.

A. Fletcher and R. Shepard, Use of (+)-mefloquine for the treatment of malaria with reduced side-effects, WO 9839003, 1998.

A. Dassonville-klimpt, C. Cézard, C. Mullié, P. Agnamey, A. Jonet et al., Absolute Configuration and Antimalarial Activity oferythro-Mefloquine Enantiomers, ChemPlusChem, vol.78, issue.7, pp.642-646, 2013.

G. L. Amidon, H. Lennernäs, V. P. Shah, and J. R. Crison, A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability, Pharm Res An Off J Am Assoc Pharm Sci, vol.12, issue.3, pp.413-433, 1995.

H. Cheng, B. Defulvio, P. Kardos, J. Wright, K. Weinstein et al., In vitro permeability and solubility study of mefloquine hydrochloride according to the biopharmaceutics classification system (BCS) guidelines, 2011.

C. Wu and L. Z. Benet, Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System, Pharmaceutical Research, vol.22, issue.1, pp.11-23, 2005.

R. Shawahna, Pediatric Biopharmaceutical Classification System: Using Age-Appropriate Initial Gastric Volume, The AAPS Journal, vol.18, issue.3, pp.728-736, 2016.

L. Z. Benet, F. Broccatelli, and T. I. Oprea, BDDCS Applied to Over 900 Drugs, The AAPS Journal, vol.13, issue.4, pp.519-547, 2011.

H. G. Kristensen, WHO guideline development of paediatric medicines: Points to consider in pharmaceutical development, International Journal of Pharmaceutics, vol.435, issue.2, pp.134-135, 2012.

W. N. Anti-infective, Remington : the science and practice of pharmacy, 2000.

J. Walsh, A. Cram, K. Woertz, J. Breitkreutz, G. Winzenburg et al., Playing hide and seek with poorly tasting paediatric medicines: Do not forget the excipients, Advanced Drug Delivery Reviews, vol.73, pp.14-33, 2014.

S. A. Thomson, C. Tuleu, I. C. Wong, S. Keady, K. G. Pitt et al., Minitablets: New Modality to Deliver Medicines to Preschool-Aged Children, PEDIATRICS, vol.123, issue.2, pp.e235-e238, 2009.

A. Patel, L. Jacobsen, R. Jhaveri, and K. K. Bradford, Effectiveness of Pediatric Pill Swallowing Interventions: A Systematic Review, PEDIATRICS, vol.135, issue.5, pp.883-889, 2015.

B. D. Lifschultz and E. R. Donoghue, Deaths Due to Foreign Body Aspiration in Children: The Continuing Hazard of Toy Balloons, Journal of Forensic Sciences, vol.41, issue.2, p.15422J, 1996.

D. Da-silva, E. Rook, N. Semis-costa, J. Mueller-berghaus, and R. Vesely, Fri0609 european medicines agency's guideline on the clinical investigation of medicinal products for the treatment of rheumatoid arthritis, FRIDAY, 15 JUNE 2018, 2018.

R. G. Strickley, Q. Iwata, S. Wu, and T. C. Dahl, Pediatric Drugs-A Review of Commercially Available Oral Formulations, Journal of Pharmaceutical Sciences, vol.97, issue.5, pp.1731-1774, 2008.

G. Schmid, Adolescent boys: who cares?, Bulletin of the World Health Organization, vol.86, issue.9, pp.659-659, 2008.

G. Schmid, Adolescent boys: who cares?, Bulletin of the World Health Organization, vol.86, issue.9, pp.659-659, 2008.

A. V. Yadav, A. P. Dabke, and A. S. Shete, Crystal engineering to improve physicochemical properties of mefloquine hydrochloride, Drug Development and Industrial Pharmacy, vol.36, issue.9, pp.1036-1045, 2010.

T. K. Mbela, E. Deharo, A. Haemers, and A. Ludwig, Biopharmaceutics: Submicron Oil-in-water Emulsion Formulations for Mefloquine and Halofantrine: Effect of Electric-charge Inducers on Antimalarial Activity in Mice, Journal of Pharmacy and Pharmacology, vol.50, issue.11, pp.1221-1225, 1998.

W. Tang, W. Tang, W. C. Chen, C. Diako, C. F. Ross et al., Development of a Rapidly Dissolvable Oral Pediatric Formulation for Mefloquine Using Liposomes, Molecular Pharmaceutics, vol.14, issue.6, pp.1969-1979, 2017.

P. V. Patil and M. K. Patil, Preparation of Animal for Show, Milk Production Management, vol.66, pp.189-190, 2020.

K. T. Savjani, A. K. Gajjar, and J. K. Savjani, Drug Solubility: Importance and Enhancement Techniques, ISRN Pharmaceutics, vol.2012, pp.1-10, 2012.

M. E. Brewster and T. Loftsson, Cyclodextrins as pharmaceutical solubilizers, Advanced Drug Delivery Reviews, vol.59, issue.7, pp.645-666, 2007.

A. W. Coleman, I. Nicolis, N. Keller, and J. P. Dalbiez, Aggregation of cyclodextrins: An explanation of the abnormal solubility of?-cyclodextrin, Journal of Inclusion Phenomena and Molecular Recognition in Chemistry, vol.13, issue.2, pp.139-143, 1992.
URL : https://hal.archives-ouvertes.fr/hal-00314685

K. Frömming and J. Szejtli, Cyclodextrins in Pharmacy, 1994.

A. C. Van-der-vossen, I. Van-der-velde, O. S. Smeets, D. J. Postma, M. Eckhardt et al., Formulating a poorly water soluble drug into an oral solution suitable for paediatric patients; lorazepam as a model drug, European Journal of Pharmaceutical Sciences, vol.100, pp.205-210, 2017.

T. Loftsson and M. E. Brewster, Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization, Journal of Pharmaceutical Sciences, vol.85, issue.10, pp.1017-1025, 1996.

P. Borman and D. Elder, Q2(R1) Validation of Analytical Procedures, ICH Quality Guidelines, pp.127-166, 2017.

P. H. Hubert, P. Chiap, J. Crommen, B. Boulanger, E. Chapuzet et al., The SFSTP guide on the validation of chromatographic methods for drug bioanalysis: from the Washington Conference to the laboratory, Analytica Chimica Acta, vol.391, issue.2, pp.135-148, 1999.

T. Higuchi and K. Connors, Phase-solubility techniques, AdvAnalChemInstr, vol.4, pp.117-139, 1965.

T. Loftsson, D. Hreinsdóttir, and M. Másson, The complexation efficiency, Journal of Inclusion Phenomena and Macrocyclic Chemistry, vol.57, issue.1-4, pp.545-552, 2007.

S. M. Buha, G. A. Baxi, and P. S. Shrivastav, Liquid Chromatography Study on Atenolol--Cyclodextrin Inclusion Complex, ISRN Analytical Chemistry, vol.2012, pp.1-8, 2012.

P. Job, Formation and Stability of Inorganic Complexes in Solution, Ann Chim, vol.9, pp.113-203, 1928.

H. A. Benesi and J. H. Hildebrand, A Spectrophotometric Investigation of the Interaction of Iodine with Aromatic Hydrocarbons, Journal of the American Chemical Society, vol.71, issue.8, pp.2703-2707, 1949.

H. H. Tønnesen and A. Grislingaas, Photochemical stability of biologically active compounds. II. Photochemical decomposition of mefloquine in water, International Journal of Pharmaceutics, vol.60, issue.2, pp.157-162, 1990.

A. Popielec and T. Loftsson, Effects of cyclodextrins on the chemical stability of drugs, International Journal of Pharmaceutics, vol.531, issue.2, pp.532-542, 2017.

D. Clapham, Stability Testing, ICH Quality Guidelines, pp.45-72, 2017.

R. Rowe, P. Sheskey, and M. Quinn, Handbook of pharmaceutical excipients, 2009.

A. L. Thakkar and P. V. Demarco, Cycloheptaamylose Inclusion Complexes of Barbiturates: Correlation between Proton Magnetic Resonance and Solubility Studies, Journal of Pharmaceutical Sciences, vol.60, issue.4, pp.652-653, 1971.

F. Marçon, D. Mathiron, S. Pilard, A. Lemaire-hurtel, J. Dubaele et al., Development and formulation of a 0.2% oral solution of midazolam containing ?-cyclodextrin, International Journal of Pharmaceutics, vol.379, issue.2, pp.244-250, 2009.

F. Djedaïni, S. Z. Lin, B. Perly, and D. Wouessidjewe, High-Field Nuclear Magnetic Resonance Techniques for the Investigation of a ?-Cyclodextrin:Indomethacin Inclusion Complex, Journal of Pharmaceutical Sciences, vol.79, issue.7, pp.643-646, 1990.

S. M. Ali and S. K. Upadhyay, Complexation study of midazolam hydrochloride with ?-cyclodextrin: NMR spectroscopic study in solution, Magnetic Resonance in Chemistry, vol.46, issue.7, pp.676-679, 2008.

A. Artiges, La pharmacopée européenne et la direction européenne de la qualité du médicament au Conseil de l?Europe, Bulletin de l'Académie Nationale de Médecine, vol.190, issue.9, pp.1903-1911, 2006.

, United States Pharmacopeia-National Formulary, Council of experts and its expert committees. U.S. Pharmacopeia, vol.34, 2020.

V. Chopade, N. B. Tembhurkar, S. B. Jadhav, and P. D. Chaudhari, Development and Validation of A Stability Indicating Assay Method of Mefloquine HCl By Using Different Stress Degradation Conditions, J Pharm Res, vol.5, issue.5, pp.2631-2636, 2012.

P. Jyothi, K. Geetha, A. Ajitha, V. Uma, M. Rao et al., Stability Indicating Method Development and Validation for Simultaneous Estimation of Mefloquine and Artesunate in Tablet Dosage Form, Sch Acad J PharmacyOnline) Sch Acad J Pharm, vol.3, issue.5, pp.2320-4206, 2014.

F. H. Nogueira, L. D. Goulart, I. D. César, L. M. De-campos, and G. A. Pianetti, Development and Validation of an HPLC Method for Mefloquine Hydrochloride Determination in Tablet Dosage Form, Journal of AOAC INTERNATIONAL, vol.94, issue.4, pp.1089-1093, 2011.

Y. Patil, S. Ahmad, V. M. Shastry, V. Shinde, and A. Sajjad, Analytical method development and validation for the simultaneous estimation of artesunate and mefloquine by reversed-phase high-performance liquid chromatography in bulk and tablet dosage forms, SPER J Anal Drug Regul Aff, vol.2, issue.2, pp.56-61, 2017.

A. Avdeef, E. Fuguet, A. Llinàs, C. Ràfols, E. Bosch et al., Equilibrium solubility measurement of ionizable drugs ? consensus recommendations for improving data quality, ADMET and DMPK, vol.4, issue.2, p.117, 2016.

S. Kitamura, L. Chang, and J. K. Guillory, Polymorphism of mefloquine hydrochloride, International Journal of Pharmaceutics, vol.101, issue.1-2, pp.127-144, 1994.

H. G. Brittain, Polymorphism in Pharmaceutical Solids, Polymorphism in pharmaceutical solids. M. Dekker, 2018.

M. Messner, S. V. Kurkov, P. Jansook, and T. Loftsson, Self-assembled cyclodextrin aggregates and nanoparticles, International Journal of Pharmaceutics, vol.387, issue.1-2, pp.199-208, 2010.

M. S. Treasa and J. P. Kumari, Characterization and Solubility Studies of Mefloquinehydrochloride Inclusion Complexes with ?-Cyclodextrin/ Hydroxypropyl ?-Cyclodextrin, Int J Sci Res Publ, vol.5, issue.7, 2015.

T. Irie and K. Uekama, Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation, Journal of Pharmaceutical Sciences, vol.86, issue.2, pp.147-162, 1997.

T. Loftsson and M. E. Brewster, Pharmaceutical applications of cyclodextrins: basic science and product development, Journal of Pharmacy and Pharmacology, vol.62, issue.11, pp.1607-1621, 2010.

A. European-medicines, European Medicines Agency (EMA), Encyclopedia of Pharmaceutical Science and Technology, Fourth Edition, pp.1449-1460, 2013.

S. Fanali and E. Camera, Use of cyclodextrins in the capillary electrophoretic separation of erythro- and threo-mefloquine enantiomers, Journal of Chromatography A, vol.745, issue.1-2, pp.17-23, 1996.

M. Thunhorst and U. Holzgrabe, Utilizing NMR spectroscopy for assessing drug enantiomeric composition, Magnetic Resonance in Chemistry, vol.36, issue.3, pp.211-216, 1998.

E. Szoko, J. Gyimesi, L. Barcza, and K. Magyar, Determination of binding constants and the influence of methanol on the separation of drug enantiomers in cyclodextrin modified capillary electrophoresis, J Chromatogr A, vol.745, pp.181-188, 1996.

D. Greatbanks and R. Pickford, Cyclodextrins as chiral complexing agents in water, and their application to optical purity measurements, Magnetic Resonance in Chemistry, vol.25, issue.3, pp.208-215, 1987.

C. Gazpio, M. Sánchez, I. X. García-zubiri, I. Vélaz, C. Martínez-ohárriz et al., HPLC and solubility study of the interaction between pindolol and cyclodextrins, Journal of Pharmaceutical and Biomedical Analysis, vol.37, issue.3, pp.487-492, 2005.

K. Uekama, F. Hirayama, S. Nasu, N. Matsuo, and T. Irie, Determination of the stability constants for inclusion complexes of cyclodextrins with various drug molecules by high performance liquid chromatography., CHEMICAL & PHARMACEUTICAL BULLETIN, vol.26, issue.11, pp.3477-3484, 1978.

R. Kuhn, D. Riester, B. Fleckenstein, and K. Wiesmüller, Evaluation of an optically active crown ether for the chiral separation of di- and tripeptides, Journal of Chromatography A, vol.716, issue.1-2, pp.371-379, 1995.

R. Stephani and V. Cesare, Optical resolution of 2-phenylsuccinic acid, J Chem Educ, vol.74, 1226.

P. Mura, G. Franchi, M. T. Faucci, A. Manderioli, and G. Bramanti, Improvement of Econazole Solubility in Multicomponent Systems with Cyclodextrins and Acids, Proceedings of the Ninth International Symposium on Cyclodextrins, pp.375-378, 1999.

H. Dodziuk, W. Ko?mi?ski, and A. Ejchart, NMR studies of chiral recognition by cyclodextrins, Chirality, vol.16, issue.2, pp.90-105, 2004.

J. T. Piechocki and K. Thoma, Pharmaceutical Photostability and Stabilization Technology, vol.445, 2006.

R. Tansley, S. Duparc, A. Priestley, J. Lotharius, F. Bull et al., A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single Enantiomer (+)-Mefloquine Compared with Racemic Mefloquine in Healthy Persons, The American Journal of Tropical Medicine and Hygiene, vol.83, issue.6, pp.1195-1201, 2010.

T. Loftsson, Cyclodextrins and the Biopharmaceutics Classification System of Drugs, J Incl Phenom Macrocycl Chem, vol.44, issue.1/4, pp.63-70, 2002.

J. Szejtli and L. Szente, Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins, European Journal of Pharmaceutics and Biopharmaceutics, vol.61, issue.3, pp.115-125, 2005.